Evidence map›Paper›PMID 26620564›Full record

ArticleThe Journal of biological chemistry2016

Lipid Requirements for the Enzymatic Activity of MraY Translocases and in Vitro Reconstitution of the Lipid II Synthesis Pathway.

Erik Henrich, Yi Ma, Ina Engels, Daniela Münch, Christian Otten, Tanja Schneider, Beate Henrichfreise, Hans-Georg Sahl, Volker Dötsch, Frank Bernhard

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
7.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 64 citations in OpenAlex.

  1. Article
  2. Lipopeptide antibiotics disrupt interactions of undecaprenyl phosphate with UptA.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. The antibacterial activity of berberine againstFrontiers in microbiology · 2023
    Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Frontiers in microbiology · 2021
    Article
  14. Article
  15. Co-Translational Protein Folding in Lipid Membranes.Trends in biochemical sciences · 2019
    Review
  16. Review
  17. Article
  18. Structure and activity of lipid bilayer within a membrane-protein transporter.Proceedings of the National Academy of Sciences of the United States of America · 2018
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 2 countries.

Erik HenrichFrom the Institute of Biophysical Chemistry, Centre for Biomolecular Magnetic Resonance, J. W. Goethe-University, 60438 Frankfurt-am-Main, Germany.
Yi MaFrom the Institute of Biophysical Chemistry, Centre for Biomolecular Magnetic Resonance, J. W. Goethe-University, 60438 Frankfurt-am-Main, Germany, the School of Bioscience and Bioengineering, South China University of Technology, 510006 Guangzhou, China, bimayikobe@scut.edu.cn.
Ina Engelsthe Institute for Pharmaceutical Microbiology, University of Bonn, Germany, and the German Centre for Infection Research (DZIF), partner site Cologne-Bonn, 53115 Bonn, Germany.
Daniela Münchthe Institute for Pharmaceutical Microbiology, University of Bonn, Germany, and.
Christian Ottenthe Institute for Pharmaceutical Microbiology, University of Bonn, Germany, and.
Tanja Schneiderthe Institute for Pharmaceutical Microbiology, University of Bonn, Germany, and the German Centre for Infection Research (DZIF), partner site Cologne-Bonn, 53115 Bonn, Germany.
Beate Henrichfreisethe Institute for Pharmaceutical Microbiology, University of Bonn, Germany, and.
Hans-Georg Sahlthe Institute for Pharmaceutical Microbiology, University of Bonn, Germany, and the German Centre for Infection Research (DZIF), partner site Cologne-Bonn, 53115 Bonn, Germany.
Volker DötschFrom the Institute of Biophysical Chemistry, Centre for Biomolecular Magnetic Resonance, J. W. Goethe-University, 60438 Frankfurt-am-Main, Germany.
Frank BernhardFrom the Institute of Biophysical Chemistry, Centre for Biomolecular Magnetic Resonance, J. W. Goethe-University, 60438 Frankfurt-am-Main, Germany, fbern@bpc.uni-frankfurt.de.
University of Bonn · DEGoethe University Frankfurt · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Screening of new compounds directed against key protein targets must continually keep pace with emerging antibiotic resistances. Although periplasmic enzymes of bacterial cell wall biosynthesis have been among the first drug targets, compounds directed against the membrane-integrated catalysts are hardly available. A promising future target is the integral membrane protein MraY catalyzing the first membrane associated step within the cytoplasmic pathway of bacterial peptidoglycan biosynthesis. However, the expression of most MraY homologues in cellular expression systems is challenging and limits biochemical analysis. We report the efficient production of MraY homologues from various human pathogens by synthetic cell-free expression approaches and their subsequent characterization. MraY homologues originating from Bordetella pertussis, Helicobacter pylori, Chlamydia pneumoniae, Borrelia burgdorferi, and Escherichia coli as well as Bacillus subtilis were co-translationally solubilized using either detergent micelles or preformed nanodiscs assembled with defined membranes. All MraY enzymes originating from Gram-negative bacteria were sensitive to detergents and required nanodiscs containing negatively charged lipids for obtaining a stable and functionally folded conformation. In contrast, the Gram-positive B. subtilis MraY not only tolerates detergent but is also less specific for its lipid environment. The MraY·nanodisc complexes were able to reconstitute a complete in vitro lipid I and lipid II forming pipeline in combination with the cell-free expressed soluble enzymes MurA-F and with the membrane-associated protein MurG. As a proof of principle for future screening platforms, we demonstrate the inhibition of the in vitro lipid II biosynthesis with the specific inhibitors fosfomycin, feglymycin, and tunicamycin.

Indexed as

Bacillus subtilisBacterial ProteinsBiosynthetic PathwaysBordetella pertussisBorrelia burgdorferiCell-Free SystemCell WallChlamydophila pneumoniaeCytoplasmDetergentsDNAEscherichia coliFosfomycinHelicobacter pyloriMicellesMonosaccharidesBacterial ProteinsDetergentsDNAfeglymycinFosfomycinlipid IMicellesMonosaccharidesmraY protein, Bacteriamuramyl-NAc-(pentapeptide)pyrophosphoryl-undecaprenolOligopeptidesPeptidesPeptidoglycanProteinsRecombinant ProteinsTransferasesTransferases (Other Substituted Phosphate Groups)TunicamycinUridine Diphosphate N-Acetylmuramic Acidcell-free expressionlipid IIlipid-protein interactionmembrane enzymenanodiscpeptidoglycanprotein foldingrecombinant protein expressionsynthetic biology

Identifiers

PMID26620564
PMCPMC4732233
OpenAlexW2186799722

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.